Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Biden initiative marks a turning point in a long-fought battle to control ever-rising drug prices.
In the 1980s, AZT was labeled the most expensive drug in history at $8,000 annually. Now, scores of drugs cost more than $50,000 a year.
The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.
While expensive new drugs are developed, thousands of people can’t get a drug like cisplatin that costs as little as $6 a dose.
A nationwide shortage of cancer drugs is causing thousands of patients to experience delays in treatment.
Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.
HIV clinics could lose over $100 million each year—notably those serving Black, brown, queer and Southern communities.
Several formulations of generic Truvada are now available at a lower cost.
Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.
A low-cost generic version of Truvada as PrEP will hit the market September 30.
Fact-checkers and HIV advocates break down the president’s State of the Union boasts.
The FDA has found a probable cancer-causing contaminant in generic drugs shipped from abroad––most recently, Zantac (ranitidine).
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
The FDA commissioner wants drugmakers to “end the shenanigans.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.